Allogeneic stem cell transplantation with matched sibling donor versus autologous stem cell transplantation for newly diagnosed Multiple Myeloma

  • Protocol
  • Intervention

Authors


Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To compare the effects of the use of autologous stem cell transplantation (ASCT), which includes single ASCT and tandem ASCT, versus allogeneic stem cell transplantation (alloSCT) from a matched sibling donor, which includes single alloSCT, non-myeloablative alloSCT and ASCT-alloSCT, in patients with multiple myeloma (MM).